copd {MBNMAtime}R Documentation

Studies comparing Tiotropium, Aclidinium and Placebo for maintenance treatment of moderate to severe chronic obstructive pulmonary disease

Description

A dataset from a systematic review of Randomised-Controlled Trials (RCTs) for maintenance treatment of moderate to severe chronic obstructive pulmonary disease (COPD) (Karabis et al. 2013). Data are extracted from (Tallarita et al. 2019). SEs were imputed for three studies, and number of patients randomised were imputed for one study (LAS 39) in which they were missing, using the median standard deviation calculated from other studies in the dataset. The outcome is trough Forced Expiratory Volume in 1 second (FEV1), measured in litres and reported in each study arm as mean change from baseline to follow-up. The dataset includes 13 Randomised-Controlled Trials (RCTs), comparing 2 treatments (Tiotropium and Aclidinium) and placebo.

Usage

copd

Format

A data frame in long format (one row per arm and study), with 80 rows and 6 variables:

Details

copd is a data frame in long format (one row per observation, arm and study), with the variables studyID, time, y, se, treatment, and n.

References

Karabis A, Lindner L, Mocarski M, Huisman E, Greening A (2013). “Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis.” Int J Chron Obstruct Pulmon Dis, 8, 405-423. doi:10.2147/COPD.S48967, https://pubmed.ncbi.nlm.nih.gov/24043936/.

Tallarita M, De lorio M, Baio G (2019). “A comparative review of network meta-analysis models in longitudinal randomized controlled trial.” Statistics in Medicine, 38(16), 3053-3072. doi:10.1002/sim.8169.


[Package MBNMAtime version 0.2.4 Index]